According to ChemAnalyst, The Rabeprazole Prices moved higher across key regions during the second quarter of 2026, supported by increased production costs, firm pharmaceutical demand, and supply-side constraints affecting raw materials. Rabeprazole, a proton pump inhibitor (PPI) widely used in medicines for acid-related gastrointestinal disorders, is an important active pharmaceutical ingredient (API) for manufacturers of prescription and generic formulations. During Q2 2026